Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Clinical data on pomalidomide in myelofibrosis patients disclosed at ASH meeting

Dec. 28, 2009

Encouraging phase I data reported for TRU-016 in relapsed/refractory CLL

Dec. 28, 2009

Vadimezan added to taxane-containing regimens evaluated in mouse breast cancer models

Dec. 24, 2009

Fluticasone furoate nasal spray may be beneficial in children with otitis media

Dec. 24, 2009

GP2/GM-CSF peptide vaccine may prevent breast cancer recurrence

Dec. 24, 2009

BHQ-880 shown to be safe in combination with zoledronic acid and MM therapy

Dec. 24, 2009

TG-101348 reduces JAK2 V617F allele burden in phase I myelofibrosis trial

Dec. 24, 2009

Fusion protein ACE-435 shows promise in cancer-induced cachexia therapy

Dec. 23, 2009

AZD-1152 displays safety and efficacy in AML phase I/II trial

Dec. 23, 2009

SS-1020, a new anti-estrogen candidate for treatment and prevention of breast cancer

Dec. 23, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026